Cvs Health Corp Stock Price, News & Analysis

CVS Health Foundation has launched a $5 million Health Care Careers Scholarship program over five years, aimed at supporting Black and Latinx students pursuing health care degrees. This initiative is part of CVS's broader $600 million commitment to address racial inequities. Scholarships will target students in various health care-related fields and will be managed in collaboration with UNCF. Applications are open from February 1 to April 1, 2021, fostering a diverse pipeline of future health care professionals.

CVS Health has successfully administered the first round of COVID-19 vaccine doses to nearly 8,000 skilled nursing facilities across the U.S. With second doses already underway, CVS anticipates completion within four weeks. The rollout included more than 40,000 long-term care facilities, with first doses expected to be finished by mid-February. CVS can administer 20-25 million vaccine shots monthly, significantly impacting community vaccination efforts in partnership with federal programs.

CVS Health announces the appointment of Laurie Havanec as Executive Vice President and Chief People Officer, effective February 8, 2021. She succeeds Lisa Bisaccia, who is retiring after 16 years. Havanec brings over 20 years of HR experience, most recently from Otis Worldwide Co., and has previously held significant roles at United Technologies Corporation and Aetna. Havanec aims to enhance talent and culture initiatives, supporting CVS's strategy with a focus on engaging its workforce of 300,000 employees.

CVS Health (NYSE: CVS) has appointed Michelle Peluso as its first-ever Chief Customer Officer, effective January 25, 2021. This new executive role will focus on transforming the consumer experience and enhancing CVS's digital strategy. Peluso, who has over 25 years of experience, previously held senior positions at IBM and Citigroup, managing substantial revenue and improving customer engagement. Her addition aims to provide a personalized and seamless experience for customers within CVS Health's diverse healthcare offerings.

CVS Health is administering COVID-19 vaccines in skilled nursing facilities across 49 states, starting in 36 states and Washington, D.C. The first doses are expected to be completed by January 25. Approximately 8,000 out of 15,000 skilled nursing facilities have partnered with CVS. While the uptake among residents is high, initial staff vaccination rates are low, attributed to staggered visits. CVS plans to expand vaccine availability at retail locations based on state decisions. The company can administer 20-25 million shots per month.

CVS Health Corporation (NYSE: CVS) has declared a quarterly dividend of $0.50 per share on its common stock. This dividend will be payable on February 1, 2021, to shareholders of record as of January 22, 2021. CVS Health continues to enhance its health services, engaging nearly one in three Americans annually and focusing on improving healthcare accessibility and affordability through innovative services and community presence.

CVS Health Corporation (NYSE: CVS) announced its participation in the J.P. Morgan 39th Annual Healthcare Conference on January 12, 2021. Key executives will include President and CEO Larry Merlo, CFO Eva Boratto, and incoming CEO Karen Lynch, who will engage in a fireside chat at 10:50 a.m. ET. Additionally, Lynch will take part in a vaccine panel discussion at 12:45 AM ET on January 13, 2021. CVS Health continues to focus on improving healthcare accessibility and affordability.

CVS Health Corporation announced cash tender offers totaling $4.5 billion for three groups of senior notes: up to $1.5 billion for 2023 Notes, $1.049 billion for 2025 Notes, and $1.950 billion for 2028 Notes. The total consideration and reference yields for the notes were detailed in the press release. The offers are open to registered holders until January 6, 2021, and the early settlement date is December 22, 2020. CVS expects to accept validly tendered notes on a prorated basis due to maximum amounts being reached.

CVS Health has launched its COVID-19 vaccination program for long-term care facilities, addressing the needs of residents disproportionately affected by the pandemic. Starting December 21, CVS teams will administer the Pfizer vaccine in 12 states, aiming to vaccinate up to four million individuals across more than 40,000 facilities. The program will involve three visits per facility for each resident and staff member. CVS anticipates completing the vaccination efforts in about 12 weeks, with plans to expand availability to all pharmacy locations in the coming months.